PL3668853T3 - Nowe związki - Google Patents
Nowe związkiInfo
- Publication number
- PL3668853T3 PL3668853T3 PL18752172T PL18752172T PL3668853T3 PL 3668853 T3 PL3668853 T3 PL 3668853T3 PL 18752172 T PL18752172 T PL 18752172T PL 18752172 T PL18752172 T PL 18752172T PL 3668853 T3 PL3668853 T3 PL 3668853T3
- Authority
- PL
- Poland
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382570 | 2017-08-16 | ||
| EP18752172.9A EP3668853B1 (en) | 2017-08-16 | 2018-08-15 | Novel compounds |
| PCT/EP2018/072144 WO2019034701A1 (en) | 2017-08-16 | 2018-08-15 | NEW COMPOUNDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3668853T3 true PL3668853T3 (pl) | 2022-01-31 |
Family
ID=59713958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18752172T PL3668853T3 (pl) | 2017-08-16 | 2018-08-15 | Nowe związki |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11969423B2 (pl) |
| EP (1) | EP3668853B1 (pl) |
| JP (1) | JP7183270B2 (pl) |
| KR (1) | KR102657861B1 (pl) |
| CN (1) | CN111225910B (pl) |
| AU (1) | AU2018317805B2 (pl) |
| BR (1) | BR112020003221A2 (pl) |
| CA (1) | CA3072839A1 (pl) |
| CY (1) | CY1124865T1 (pl) |
| DK (1) | DK3668853T3 (pl) |
| ES (1) | ES2902600T3 (pl) |
| HR (1) | HRP20211894T1 (pl) |
| HU (1) | HUE057050T2 (pl) |
| LT (1) | LT3668853T (pl) |
| PL (1) | PL3668853T3 (pl) |
| PT (1) | PT3668853T (pl) |
| RS (1) | RS62718B1 (pl) |
| RU (1) | RU2767652C2 (pl) |
| SI (1) | SI3668853T1 (pl) |
| WO (1) | WO2019034701A1 (pl) |
| ZA (1) | ZA202000586B (pl) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10250080A1 (de) | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| FR2903405B1 (fr) | 2006-07-04 | 2011-09-09 | Pasteur Institut | Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications |
| CA2673580C (en) | 2006-12-29 | 2015-11-24 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
| FR2939135B1 (fr) * | 2008-12-02 | 2010-12-03 | Galderma Res & Dev | Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| EP2771338A2 (en) | 2011-10-25 | 2014-09-03 | Université de Droit et de la Santé de Lille 2 | 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis |
| FR3000065A1 (fr) * | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes |
-
2018
- 2018-08-15 JP JP2020530728A patent/JP7183270B2/ja active Active
- 2018-08-15 US US16/639,246 patent/US11969423B2/en active Active
- 2018-08-15 CA CA3072839A patent/CA3072839A1/en active Pending
- 2018-08-15 LT LTEPPCT/EP2018/072144T patent/LT3668853T/lt unknown
- 2018-08-15 PL PL18752172T patent/PL3668853T3/pl unknown
- 2018-08-15 WO PCT/EP2018/072144 patent/WO2019034701A1/en unknown
- 2018-08-15 SI SI201830478T patent/SI3668853T1/sl unknown
- 2018-08-15 CN CN201880067415.7A patent/CN111225910B/zh active Active
- 2018-08-15 RU RU2020109672A patent/RU2767652C2/ru active
- 2018-08-15 HU HUE18752172A patent/HUE057050T2/hu unknown
- 2018-08-15 PT PT187521729T patent/PT3668853T/pt unknown
- 2018-08-15 EP EP18752172.9A patent/EP3668853B1/en active Active
- 2018-08-15 DK DK18752172.9T patent/DK3668853T3/da active
- 2018-08-15 AU AU2018317805A patent/AU2018317805B2/en active Active
- 2018-08-15 ES ES18752172T patent/ES2902600T3/es active Active
- 2018-08-15 BR BR112020003221-2A patent/BR112020003221A2/pt unknown
- 2018-08-15 HR HRP20211894TT patent/HRP20211894T1/hr unknown
- 2018-08-15 RS RS20211557A patent/RS62718B1/sr unknown
- 2018-08-15 KR KR1020207007145A patent/KR102657861B1/ko active IP Right Grant
-
2020
- 2020-01-29 ZA ZA2020/00586A patent/ZA202000586B/en unknown
-
2021
- 2021-12-17 CY CY20211101110T patent/CY1124865T1/el unknown
-
2024
- 2024-04-29 US US18/649,196 patent/US20240307385A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2020109672A3 (pl) | 2021-10-18 |
| HRP20211894T1 (hr) | 2022-08-19 |
| ES2902600T3 (es) | 2022-03-29 |
| EP3668853A1 (en) | 2020-06-24 |
| WO2019034701A1 (en) | 2019-02-21 |
| CN111225910B (zh) | 2023-03-24 |
| JP2020531576A (ja) | 2020-11-05 |
| DK3668853T3 (da) | 2021-12-06 |
| CA3072839A1 (en) | 2019-02-21 |
| AU2018317805B2 (en) | 2021-04-15 |
| LT3668853T (lt) | 2022-03-10 |
| KR20200041345A (ko) | 2020-04-21 |
| RU2020109672A (ru) | 2021-09-16 |
| US20200253967A1 (en) | 2020-08-13 |
| ZA202000586B (en) | 2021-08-25 |
| EP3668853B1 (en) | 2021-09-29 |
| AU2018317805A1 (en) | 2020-02-20 |
| JP7183270B2 (ja) | 2022-12-05 |
| RS62718B1 (sr) | 2022-01-31 |
| PT3668853T (pt) | 2021-12-02 |
| US11969423B2 (en) | 2024-04-30 |
| BR112020003221A2 (pt) | 2020-10-06 |
| CY1124865T1 (el) | 2022-11-25 |
| CN111225910A (zh) | 2020-06-02 |
| KR102657861B1 (ko) | 2024-04-17 |
| HUE057050T2 (hu) | 2022-04-28 |
| SI3668853T1 (sl) | 2022-02-28 |
| RU2767652C2 (ru) | 2022-03-18 |
| US20240307385A1 (en) | 2024-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201702947D0 (en) | Novel compounds | |
| IL272562A (en) | new compounds | |
| GB201720187D0 (en) | Novel Compounds | |
| ZA202000586B (en) | Novel compounds | |
| GB201721736D0 (en) | Novel Compounds | |
| GB201721732D0 (en) | Novel Compounds | |
| GB201721735D0 (en) | Novel Compounds | |
| GB201721726D0 (en) | Novel compounds | |
| GB201721731D0 (en) | Novel compounds | |
| GB201721729D0 (en) | Novel compounds | |
| GB201721727D0 (en) | Novel compounds | |
| GB201719720D0 (en) | Novel compounds | |
| GB201718561D0 (en) | Novel compounds | |
| GB201718565D0 (en) | Novel compounds | |
| GB201718564D0 (en) | Novel compounds | |
| GB201718563D0 (en) | Novel compounds | |
| GB201716131D0 (en) | Novel compounds | |
| GB201714699D0 (en) | Novel compounds | |
| GB201713079D0 (en) | Novel Compounds | |
| GB201713076D0 (en) | Novel compounds | |
| GB201713083D0 (en) | Novel compounds | |
| GB201713082D0 (en) | Novel compounds | |
| GB201711682D0 (en) | Novel compounds | |
| GB201711549D0 (en) | Novel compounds | |
| GB201710943D0 (en) | Novel Compounds |